Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Advanced Medical Isotope Corporation (RDGL) had Return on Investments of -30.13% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.04M |
|
$-0.83M |
|
$0.04M |
|
$-0.00M |
|
$0.69M |
|
$-0.65M |
|
$-0.18M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
$-0.65M |
|
$-0.65M |
|
490.70M |
|
490.70M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$2.44M |
|
$0.34M |
|
$0.44M |
|
$2.88M |
|
$0.05M |
|
-- |
|
$0.07M |
|
$0.12M |
|
$-6.59M |
|
$2.76M |
|
$2.76M |
|
494.21M |
|
| Cash Flow Statement Financials | |
$-1.17M |
|
$-0.25M |
|
$2.19M |
|
$1.56M |
|
$2.34M |
|
$0.78M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
48.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.73% |
|
-1798.16% |
|
-1798.16% |
|
-- |
|
-2280.74% |
|
-2280.74% |
|
$-1.42M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.68 |
|
2.33 |
|
38.70 |
|
12.59% |
|
-30.13% |
|
-28.83% |
|
|
Return on Investments |
-30.13% |
$0.01 |
|
$-0.00 |
|
$-0.00 |
|